Browse All

Current Filters

CLEAR FILTER x

TITLE

Ataluren Slows the Decline of Muscle Function in Patents with nmDMD: A Meta-analysis of Three Randomized, Double-blind, Placebo-controlled Trials

Author:Jong, Yuh-Jyh   Karachunski, Peter   Statland, Jeffrey   Lorentzos, Michelle   Cairns, Anita   Takeshima, Yasuhiro   Haginoya, Kazuhiro   Penematsa, Vinay   Chou, Connie   Williams, Paula   Werner, Christian   

Session Name:P3: Neuromuscular and Clinical Neurophysiology (EMG): Genetic Muscle Diseases  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P3.002  

Author Institution:Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan  University of Minnesota, Minneapolis, MN  University of Kansas Medical Center, Kansas City, KS  The Children's Hospital at Westmead, Westmead, Australia  Queensland Chlidren's Hospital, South Brisbane, Australia  Hyogo Medical University, Nishinomya, Japan  Miyagi Children'S Hospital, Sendai, Japan  PTC Therapeutics, Inc, South Plainfield, NJ  PTC Therapeutics, Inc., South Plainfield, NJ  

Real-world Experience of Switching Treatments from Alglucosidase Alfa to Avalglucosidase Alfa for Patients Enrolled in the Pompe Registry

Author:Dimachkie, Mazen   Kishnani, Priya   Abbott, Mary-Alice   Toscano, Antonio   Foster, Meredith   Sparks, Susan   Schoser, Benedikt   

Session Name:P3: Neuromuscular and Clinical Neurophysiology (EMG): Genetic Muscle Diseases  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P3.007  

Author Institution:University of Kansas Medical Center, Kansas City, KS  Duke University Medical Center, Durham, NC  Baystate Health, Springfield, MA  Reference Center for Rare Neuromuscular Disorders, University of Messina, Messina, Italy  Sanofi, Cambridge, MA  Friedrich-Baur-Institute, Ludwig-Maximilians-University Klinikum München, Munich, Germany  

Clinical Benefit of Transcutaneous Afferent Patterned Stimulation in Essential Tremor Patients with High Unmet Need

Author:Pahwa, Rajesh   Isaacson, Stuart   Brillman, Salima   Lu, Chiahao   Kent, Alexander   

Session Name:P3: Movement Disorders: Essential Tremor and Other Tremor Disorders  

Topic:Movement Disorders  

Program Number:P3.010  

Author Institution:University of Kansas Medical Center, Kansas City, KS  Parkinson's Dis & Mov Dis Ctr of Boca Raton, Boca Raton, FL  Parkinson's Disease and Movement Disorders Center of Silicon Valley, Palo Alto, CA  Cala Health, San Mateo, CA  

Wrong Diagnoses Prior to the Ultimate Diagnosis of Late-onset Pompe Disease: A Multicenter Experience

Author:Huang, Dennis   Wencel, Marie   Biliciler, Suur   Hussain, Yessar   Ladha, Shafeeq   Heim, Andrew   Dimachkie, Mazen   Pestronk, Alan   Mozaffar, Tahseen   

Session Name:P3: Neuromuscular and Clinical Neurophysiology (EMG): Genetic Muscle Diseases  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P3.011  

Author Institution:University of California Irvine, Orange, CA  University of Texas Health Science Center at Houston, Houston, TX  Austin Neuromuscular Center, Austin, TX  Barrow Neurological Institute, Phoenix, AZ  University of Kansas Medical Center, Kansas City, KS  Washington University in Saint Louis - Neurology, Saint Louis, MO  

Evaluation of Autoantibody Status Effect on Dermatomyositis Patients’ Response to IVIG Treatment: Post-hoc Analysis of the ProDERM Trial

Author:Dimachkie, Mazen   Charles-Schoeman, Christina   Schessl, Joachim   Clodi, Elisabeth   Aggarwal, Rohit   

Session Name:P4: Autoimmune Neurology: Peripheral Autoimmunity  

Topic:Autoimmune Neurology  

Program Number:P4.007  

Author Institution:University of Kansas Medical Center, Kansas City, KS  UCLA, Los Angeles, CA  Friedrich-Baur Institute, Ludwig-Maximilians University of Munich, Munich, Germany  Octapharma Pharm. ProduduktionsgesmbH, Vienna, Austria  University of Pittsburgh, Pittsburgh, PA